155 related articles for article (PubMed ID: 36150349)
21. [Intensive pharmacovigilance of clozapine in Argentina].
Balda MV; Daray FM
Vertex; 2015; 26(122):292-301. PubMed ID: 26672506
[TBL] [Abstract][Full Text] [Related]
22. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database.
de Filippis R; De Las Cuevas C; Sanz EJ; Schoretsanitis G; Correll CU; de Leon J
Schizophr Res; 2024 Jun; 268():118-130. PubMed ID: 37981478
[TBL] [Abstract][Full Text] [Related]
23. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.
de Leon J; Arrojo-Romero M; Verdoux H; Ruan CJ; Schoretsanitis G; Rohde C; Cohen D; Schulte PFJ; Kim SH; Cotes RO; Leung JG; Otsuka Y; Kirilochev OO; Baptista T; Grover S; Every-Palmer S; Clark SR; McGrane IR; Motuca M; Olmos I; Wilkowska A; Sagud M; Anil Yağcioğlu AE; Ristic DI; Lazary J; Sanz EJ; De Las Cuevas C
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):239-245. PubMed ID: 37068034
[TBL] [Abstract][Full Text] [Related]
24. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
Sato K; Mano T; Iwata A; Toda T
J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
[TBL] [Abstract][Full Text] [Related]
25. Is it possible to identify risk factors for adverse drug reactions using a pharmacovigilance database based on spontaneous reporting?
Noguchi Y; Yoshimura T
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5737. PubMed ID: 37985422
[No Abstract] [Full Text] [Related]
26. Identification of risk factors for adverse drug reactions in a pharmacovigilance database.
Attelind S; Eriksson N; Sundström A; Wadelius M; Hallberg P
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5753. PubMed ID: 38169128
[No Abstract] [Full Text] [Related]
27. Antipsychotics and Drug-Induced Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies.
Raschi E; Schoretsanitis G; Gastaldon C; Khouri C; Salvo F; De Ponti F
J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):81-83. PubMed ID: 36584260
[No Abstract] [Full Text] [Related]
28. Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database.
Hatano M; Yamada K; Matsuzaki H; Yokoi R; Saito T; Yamada S
PLoS One; 2023; 18(6):e0287122. PubMed ID: 37307250
[TBL] [Abstract][Full Text] [Related]
29. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
30. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study.
Kawakita Y; Takeshima M; Komatsu T; Imanishi A; Fujiwara D; Itoh Y; Mishima K
BMC Psychiatry; 2022 Oct; 22(1):653. PubMed ID: 36271340
[TBL] [Abstract][Full Text] [Related]
31. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
32. Real world analysis of cardiac adverse events associated with clozapine: A pharmacovigilance analysis using food and drug administration adverse event reporting system.
Thotamgari SR; Bath AS; Dhaliwal L; Kommineni SK; Aujla P; Brar V
Gen Hosp Psychiatry; 2022; 78():123-125. PubMed ID: 35396035
[No Abstract] [Full Text] [Related]
33. Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.
Bettuzzi T; Drucker A; Staumont-Sallé D; Bihan K; Lebrun-Vignes B; Sbidian E
J Am Acad Dermatol; 2022 Feb; 86(2):431-433. PubMed ID: 34600034
[No Abstract] [Full Text] [Related]
34. Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database.
Campillo JT; Faillie JL
Therapie; 2022; 77(6):747-749. PubMed ID: 35606189
[No Abstract] [Full Text] [Related]
35. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
36. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
Kumlien E; Lundberg PO
Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.
Coulter DM; Bate A; Meyboom RH; Lindquist M; Edwards IR
BMJ; 2001 May; 322(7296):1207-9. PubMed ID: 11358771
[TBL] [Abstract][Full Text] [Related]
39. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
40. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
